A detailed history of Lgt Group Foundation transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lgt Group Foundation holds 739,501 shares of MRK stock, worth $72.1 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
739,501
Previous 697,137 6.08%
Holding current value
$72.1 Million
Previous $86.3 Million 2.7%
% of portfolio
1.38%
Previous 1.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$111.15 - $128.97 $4.71 Million - $5.46 Million
42,364 Added 6.08%
739,501 $84 Million
Q2 2024

Aug 07, 2024

BUY
$123.8 - $132.96 $1.58 Million - $1.7 Million
12,758 Added 1.86%
697,137 $86.3 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $921,433 - $1.07 Million
-8,137 Reduced 1.17%
684,379 $90.3 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $1.32 Million - $1.44 Million
-13,191 Reduced 1.87%
692,516 $75.5 Million
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $2.47 Million - $2.74 Million
23,964 Added 3.52%
705,707 $72.7 Million
Q2 2023

Jul 27, 2023

BUY
$108.61 - $118.38 $34.5 Million - $37.6 Million
318,015 Added 87.43%
681,743 $78.7 Million
Q1 2023

Apr 20, 2023

BUY
$102.94 - $114.86 $316,540 - $353,194
3,075 Added 0.85%
363,728 $38.7 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $541,428 - $694,185
6,192 Added 1.75%
360,653 $40 Million
Q3 2022

Oct 19, 2022

BUY
$84.53 - $94.96 $4.9 Million - $5.5 Million
57,925 Added 19.53%
354,461 $30.5 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $9 Million - $10.2 Million
107,813 Added 57.13%
296,536 $27 Million
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $3.83 Million - $4.3 Million
52,145 Added 38.18%
188,723 $15.8 Million
Q4 2021

May 03, 2022

BUY
$72.28 - $90.54 $9.87 Million - $12.4 Million
136,578 New
136,578 $10.5 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.